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The Gardos channel is a Ca2+ sensitive, K+ selective channel present in several tissues including RBCs, 
where it is involved in cell volume regulation. Recently, mutations at two different aminoacid residues 
in KCNN4 have been reported in patients with hereditary xerocytosis. We identified by whole exome 
sequencing a new family with two members affected by chronic hemolytic anemia carrying mutation 
R352H in the KCNN4 gene. No additional mutations in genes encoding for RBCs cytoskeletal, membrane 
or channel proteins were detected. We performed functional studies on patients’ RBCs to evaluate the 
effects of R352H mutation on the cellular properties and eventually on the clinical phenotype. Gardos 
channel hyperactivation was demonstrated in circulating erythrocytes and erythroblasts differentiated 
ex-vivo from peripheral CD34+ cells. Pathological alterations in the function of multiple ion transport 
systems were observed, suggesting the presence of compensatory effects ultimately preventing cellular 
dehydration in patient’s RBCs; moreover, flow cytometry and confocal fluorescence live-cell imaging 
showed Ca2+ overload in the RBCs of both patients and hypersensitivity of Ca2+ uptake by RBCs to 
swelling. Altogether these findings suggest that the ‘Gardos channelopathy’ is a complex pathology, to 
some extent different from the common hereditary xerocytosis.
The Gardos channel is a Ca2+ sensitive, intermediate conductance, K+ selective channel present in several cell 
types including red blood cells (RBCs)1, where it is involved in cell volume regulation. Activation of the channel 
in response to elevation of cytosolic Ca2+ in human erythrocytes causes transient cell shrinkage due to the efflux 
of K+ and concomitantly of Cl−, a phenomenon referred to as Gardos effect2. Patch-clamp experiments have 
shown that local membrane deformations may act as a stimulating event leading to Gardos channel activation in 
RBCs, providing evidence for the role of this mechanosensory mechanism in shaping and volume modifications 
of erythrocytes3.
In the last years Gardos channel has been identified as an interesting therapeutic target in human diseases4, 
5; in particular, its inhibition in sickle cell disease patients has shown to reduce RBC dehydration and hemolysis, 
and to increase hemoglobin levels despite the lack of any reduction in the frequency of pain episodes6–8.
Gardos channel (KCa3.1) is a tetramer of 4 identical subunits, encoded by the KCNN4 gene9. Recurrent muta-
tions at two different aminoacid residues in KCNN4 (R352H, V282M/E) have been reported in patients from 
6 independent families with dehydrated hereditary stomatocytosis (DHSt)10, 11, 12. In a recent paper aimed at 
studying the effect of the Gardos channel inhibitor Senicapoc, it was observed that the three mutants result in 
a higher channel activity, although they do not share a common mechanism in altering channel characteristics, 
1UOC Oncoematologia, UOS. Fisiopatologia delle Anemie Fondazione IRCCS Ca’ Granda Ospedale Maggiore 
Policlinico, Milano, Italy. 2Vetsuisse Faculty and the Zurich Center for Integrative Human Physiology (ZIHP), Institute 
of Veterinary Physiology, University of Zurich, Zurich, Switzerland. 3Research Center for Molecular Imaging and 
Screening, Medical School, Institute for Molecular Cell Biology, Saarland University, Homburg/Saar, Germany. 
4UOC Pronto soccorso, Pediatria ambulatoriale e DH/MAC. Fondazione IRCCS Ca’ Granda Ospedale Maggiore 
Policlinico, Milano, Italy. 5Universita’ degli Studi di Milano, Milano, Italy. 6Experimental Physics, Saarland University, 
Saarbruecken, Germany. 7Theoretical Medicine and Biosciences, Saarland University, Homburg/Saar, Germany. 
Correspondence and requests for materials should be addressed to P.B. (email: paola.bianchi@policlinico.mi.it)
Received: 20 December 2016
Accepted: 31 March 2017
Published: xx xx xxxx
OPEN
www.nature.com/scientificreports/
2Scientific RepoRts | 7: 1744  | DOI:10.1038/s41598-017-01591-w
i.e. Ca2+ sensitivity13. However, the link of the Gardos channel dysfunction to increased hemolysis has so far not 
been elucidated.
To get a mechanistic link between the Gardos channel mutation, the cellular properties and eventually the 
clinical phenotype, we studied two novel patients carrying KCNN4 R352H mutation performing the following 
investigations: (a) single cell patch-clamp recordings on both RBCs and RBCs precursors, (b) measure of the 
activity of single ion transporters using 86Rb+ as a tracer for K+ flux experiments, (c) evaluation of intracellular 
ions contents and RBC glycolysis (d) Ca2+ handling by fluorescence live imaging and flow cytometry on RBCs. 
We found pathological alterations in the functions of multiple ion transport systems, and metabolic glycolytic 
impairment.
Results
Hematological data. The proband (II.4), a 40 years old man of Northern Italian origin, was referred to our 
Centre for the first time at the age of 3 months for evaluation of hemolytic anemia and hepatosplenomegaly; the 
unrelated parents and three siblings were hematologically normal. Hb levels ranged 7–9 g/dL, reticulocytes 250–
350 × 109/L, osmotic fragility was decreased or normal, no defects of RBC enzymes were detected. Bone marrow 
(BM) analysis revealed erythroid hyperplasia, and measurement of RBC survival showed reduced lifespan with 
intra-splenic hemolysis. The patient was occasionally transfused during spontaneous hemolytic crises; at the age 
of 11 he underwent splenectomy and cholecystectomy at 13. After splenectomy Hb levels were maintained around 
10 g/dL, no further transfusions were required, thromboembolic events never occurred. Fibroscan, Magnetic Iron 
Detector (MID) and liver iron concentration showed moderate iron overload, consequently iron chelation was 
started.
Proband’s first daughter (III.1), born at term after an uneventful pregnancy, presented severe anemia requiring 
RBC transfusion at birth (Hb 6.1 g/dL) and at 3 months. Afterwards, until the age of 2 years, Hb levels stabilized 
to about 10 g/dL with no need of further transfusions. Her mother was hematologically normal.
Clinical and hematologic data at the time of the study are reported in Table 1. Both patients displayed mod-
erate hemolytic anemia, reticulocytosis and abnormal RBC morphology with marked anisopoikilocytosis and 
stomatocytosis. BM examination in II.4 revealed erythroid hyperplasia with some dyserythropoietic changes, in 
particular binucleated erythroblasts (Supplementary Figure 1).
RBCs properties. The osmotic gradient ektacytometry did not display the leftward shift of the curve typical 
of DHSt in both patients (Omin 142 and 149 respectively for II.4 and III.1, n.v. 136–152; OHyper 457 and 437, n.v. 
446–474) (Fig. 1A), in spite of the presence of stomatocytes in the peripheral blood smear. No differences were 
observed by performing Osmoscan curve in different conditions (fresh blood, 24 h incubation at 4 °C) and with 
different anticoagulants (heparin, EDTA).
The RBCs filterability was decreased in patient II.4 (splenectomized) and normal in III.1 (not splenectomized, 
infant). To verify that cells needed to deform in this procedure, we compared untreated healthy cell with cells 
where mechano-sensitive channels were inhibited by preincubation with 5 µM GsMTx-4. To assess the con-
tribution of the Gardos channel in filterability we pretreated cells with 10 µM of the Gardos-channel inhibitor 
TRAM-34. Both treatments resulted in a significant decrease in filterability compared to untreated controls. Pre 
incubation with 5 µM GsMTx-4 and TRAM-34 together caused further decrease in filterability (Fig. 1B).
Percoll density gradient separation showed an increased high-density cell fraction in both patients; 
medium-density fraction was shifted somewhat upwards in patient II.4 indicating an increase in MCV and a 
decrease in the average RBC density (Fig. 1C). Plasma of patients’ blood samples contained free hemoglobin. 
Hemolysis was most pronounced in II.4 sample showing disturbed filterability.
Taken together, the above reported results, in particular Osmoscan and filterability data, indicate that despite 
presence of stomatocytes, patients’ RBC didn’t show the expected dehydration. The slight differences in RBCs 
properties observed between III.1 and II.4 could be attributed to infant/adult age of the two patients and pres-
ence/absence of the spleen.
Molecular analysis. All the family members underwent whole exome sequencing. Only one candidate gene 
(KCNN4) was identified by non-synonymous heterozygous mutations with expression in hematopoietic tissues. 
A de novo heterozygous missense mutation (c.1055G > A, p.R352H) was detected in II.4 and dominantly trans-
mitted to the daughter III.1 (Fig. 2A). The mutation falling in exon 7 is involved in the calmodulin binding 
domain (CaMBD) (Fig. 2B). The mutation was confirmed by Sanger sequencing. No additional mutations in 
genes encoding for RBCs cytoskeletal, membrane or channel proteins were detected by whole exome sequencing 
in the affected patients.
Functionality of the mutated Gardos channel. Gardos channel activity was evaluated measuring 
whole-cell currents by patch-clamp and K+(86Rb+) influx from mature RBCs.
Figure 3A–C summarizes the whole-cell measurements showing raw current traces (Fig. 3A), I-V-curves 
(Fig. 3B), a comparison of the percent block by 1 μM TRAM-34 of the current at −110 mV (control vs. patient 
II.4, Fig. 3Ca) and an assessment of the difference (with and without 1 μM TRAM-34) in the standard devi-
ation (SD) of the current at −110 mV (control vs. patient II.4, Fig. 3Cb). Application of the Gardos channel 
blocker TRAM-34 reduces current amplitudes in RBCs of both healthy controls and patient II.4 (Fig. 3B). The 
effect of TRAM-34 is mostly pronounced at very negative voltages; this is fully compatible with the considerable 
inward rectification reported for the channel14 and was similarly detected in the comparison between RBCs of 
KCa3.1-knock-out and wild type mice15.
As shown in Fig. 3Ca, the patient’s cells show a tendency for an increased percentage of current block by 
TRAM-34 as assessed by mean-currents, although not statistically significant (p = 0.08); the patient’s channel 
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activity is clearly increased as judged by the comparison of the difference in the SD of current with and with-
out TRAM-34, such a difference being a read-out for Gardos currents even in cells expressing a few channels 
(Fig. 3C). In the whole-cell configuration the cytosolic Ca2+ is equilibrated with the pipette solution, i.e. equal 
Ca2+-concentration for patient II.4 and healthy controls.
These data confirm that KCNN4 R352H mutation is a gain-of-function mutation leading to increased channel 
activity.
Differences in current properties are not only characteristic of the circulating cells, but can also be tracked 
down to the polychromatic erythroblasts (EPCs) differentiated for 11–13 days ex vivo from the peripheral CD34+ 
cells. We detected an abnormal voltage-sensitivity of the Ca2+ and TRAM-34 sensitive current component in 
EPCs of the II.4 patient. Whereas erythroblasts produced from the CD34+ cells derived from healthy donors 
were insensitive to multiple depolarization-repolarization cycles, EPCs of patient II.4 responded to a repeated 
voltage steps protocol with a progressive increase in current within the positive potential range (Fig. 4). This 
increase in channel activity was associated with cell swelling that could be observed microscopically during the 
voltage-clamp recordings (data not shown). The depolarization-inducible current could be blocked by omission 
of Ca2+ from the extracellular solution, TRAM-34 supplementation, or addition of methyl isobutyl amiloride 
(MIA), an inhibitor of the Na+/H+-exchanger that prevented swelling in response to the ramp protocol appli-
cation. These findings suggest an existence of a cross-talk between the Na+ uptake and swelling induced by the 
repeated changes in the transmembrane potential on one hand, and K+ loss through the Gardos channels on the 
other.
We further extended our studies of ion movements through the RBC membrane to monitoring the unidirec-
tional K+(86Rb+) influx in cells of II.4. The fraction of K+ uptake through the Gardos channel was detected as the 
flux sensitive to TRAM-34. This component was small, but detectable in RBCs of the II.4 patient, whereas it was 
below detection limits in the cells of the healthy donor (Fig. 5A).
Activity of electroneutral transporters, Na,K-ATPase and glycolysis in mature 
RBCs. Hyper-activation of K+ flux through the Gardos channel in patient’s RBCs was accompanied by abnor-
mally high activity of chloride-dependent K+ flux mediated by Na,K,2Cl- and K,Cl-cotransporters. Abnormally 
high passive K+ loss was compensated by a 4-fold increase in Na,K-ATPase activity in patient’s RBCs (Fig. 5A). 
Intracellular Na+ content in RBCs of II.4 was doubled when compared to the healthy control (Fig. 5B), despite 
the dramatic increase in the active Na+ extrusion by the Na,K-ATPase. Ion gradients in II.4 were maintained at a 
II.4 III.1 Ref values
Gender M F
Age (yrs) 40 1
Transfusions occasional until splenectomy 2 (at birth and 3 month)
Splenectomy (age) yes (12) no
Thrombotic events no no
Hb (g/dL) 10.5 9.9 13.4–17.5/10.5–14.5*
MCV (fL) 108 81.5 80–94/70–91*
MCH (pg) 35.8 29.1 25–35/24.5–31.5*
MCHC (g/dL) 33 35.7 31–37
Reticulocytes (×109/L) 384 273 20–100
Erythroblasts (%) 8.6 n.a.
RBCs morphology
13% stomatocytes 8% stomatocytes
7% echinocytes 3% elliptocytes
6% schistocytes 3% spherocytes
5% elliptocytes
2% schistocytes
4% spherocytes
Unconj. bilirubin (mg/dL) 1.56 1.1 <1
Serum ferritin (ng/mL) 1108 97 30–400/15–150*
Plasma Na+ (mE/L) 139 137 135–145
Plasma K+ (mE/L) 4.1 4 3.3–5.1
RBC K+ (μmoles/gDW) 287.97 306.42 283.55
AGLT 55 >900 >900
Pink test 36 53 11–33
NaCl osmotic fragility normal increased
EMA binding test normal normal
Sp/B3 ratio 0.84 0.97 0.95–1.17
Abnormal hemoglobins absent absent
Table 1. Clinical and hematologic data of the patients at the time of the study. n.a. = not available. 
Sp = spectrin; B3 = band 3. *Age dependent reference values.
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cost of ATP reduction (Fig. 5C), and stimulation of glycolysis in RBCs (could be observed as a facilitated deple-
tion of plasma glucose and faster lactate production during 24 h of storage at room temperature (Glucose 2.45 vs. 
3.20 mM and Lactate 8.25 vs. 5.6 mM in II.4 and control, respectively).
Figure 1. (A) LoRRca Osmoscan profile (grey area refers to 150 normal controls); (B) Filterabilty results; 
healthy cell untreated (Ctr, white bar), pre- incubated with GsMTx-4 (upward hatched bar), TRAM-34 
(downward hatched bar) GsMTx-4 + TRAM-34 (dotted bar); patient II.4 (black shaded bar); patient III.1 (grey 
bar). All measurement were performed at least twice and significance was testes using an unpaired t-test. ** and 
***denote p < 0.01 and 0.001 respectively; (C) Separation of RBC on Percoll density gradient and % of cells in 
low density (L), medium (M) and high (D) density fractions.
Figure 2. (A) Inheritance pattern of the family. (B) Schematic representation of KCNN4 protein domains, and 
position of R352H mutation.
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Calcium handling in patients with mutated Gardos channel. We measured intracellular Ca2+ levels 
in RBCs of II.4, III.1 and controls using fluorescence live imaging and flow cytometry. Figure 6A depicts the rep-
resentative confocal images of fluo-4 fluorescence intensity proportional to the amount of free Ca2+. We observed 
an increased heterogeneity in the Ca2+ content and higher number of RBCs with extraordinary high free Ca2+ 
levels and eventual sequestration of Ca2+ in intracellular vesicles. Figure 6B shows statistical analysis of Ca2+ con-
tents. The abnormally high and heterogeneous intracellular Ca2+ content was also confirmed by flow cytometry 
in both patients. The absence of splenic sequestration of more compromised cells in patient II.4 may justify the 
higher Ca2+ content respect to III.1. The observation of high intracellular Ca2+ hints to an increased activity of 
Ca2+-permeable ion channels such as PIEZO-1, the transient receptor potential cation channels (TRPC6), the 
voltage-dependent anion selective channels (VDACs), or N-methyl aspartate receptors (NMDARs), suggesting 
that mechanical stimulation could be involved in tuning the activity of multiple ion transport pathways.
We therefore tested the sensitivity of Ca2+ uptake to mechanical stimulation (swelling). Hypoosmotic swelling 
was induced by acute supplementation of water to decrease the osmolarity to 220 mOsm. Intracellular Ca2+ was 
measured before and immediately after reduction of the osmolarity. As shown in Fig. 6(C–F), swelling triggered 
massive Ca2+ uptake in RBCs of both patients and controls. Intracellular free Ca2+ levels reached in the swollen 
cells of III.1 and, in particular, of II.4 substantially exceeded those measured in the RBCs of healthy subjects 
revealing abnormally high Ca2+ uptake in both patients.
These observations were in line with the sensitivity of the abnormally high ion currents in the EPCs of II.4 
patient, not only to TRAM-34 and omission of Ca2+, but also to MIA that abolished swelling of EPCs in response 
to the repetitive ramp protocol application (Fig. 4B).
Figure 3. Whole-cell recordings of KCNN4 (Gardos channel) currents in RBCs from healthy donors and 
patient II.4. Currents were elicited by voltage steps from −130 mV to 70 mV for 500 ms in 20 mV increments at 
Vh = −30 mV and recorded in the absence and after application of 1 µM TRAM-34, a specific Gardos channel 
blocker. (A) Raw current traces from healthy and mutated RBCs in the absence (basal) and in the presence 
of 1 µM TRAM-34 as indicated above the recordings. For clarity, in all the panels, not all the traces, but every 
second one, starting with −130 mV, are being shown. (B) Corresponding I/V-curves in the absence of 1 µM 
TRAM-34, basal (grey diamonds) and in the presence of 1 µM TRAM-34 (black triangles) for healthy (Ctr) and 
mutated (II.4) RBCs. Data are expressed as mean current ± SEMs. (C) Differences in Gardos currents between 
healthy (n = 27 cells) and mutated RBCs (n = 23 cells) at −110 mV. (Ca) compares the percent of block (by 1 µM 
TRAM-34) of mean currents in healthy and mutated RBCs. Due to the small number and small single channel 
conductivity of Gardos channels in RBCs an additional assessment of Gardos currents is given by analysis of 
the kinetics of current traces. A mean whole-cell current being the result from the summation of many smaller 
unit currents flowing through single ion channels, exhibits fluctuations or “noise” about its mean level. (Cb) 
compares the difference in the standard deviation (SD) of current traces (with and without 1 µM TRAM-34) 
between control and patient RBCs. Significance was checked based on an unpaired t-test *p < 0.05.
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Discussion
In this paper we report a new family with two members affected by chronic hemolytic anemia associated with the 
R352H mutation in the KCNN4 gene encoding the Gardos channel.
Mutation R352H is located in the calmodulin binding domain of the Gardos channel. As also shown by 
Rapetti-Mauss et al.10, 13, the mutation not only changes the Ca2+ sensitivity affecting the channel threshold of 
activation, but modifies its functional properties per se resulting in a more active channel, the higher activity 
possibly due to altered open probability or unitary conductance.
The slightly bigger endogenous current observed in the case studied by Rapetti-Mauss et al.13, compared to 
our observations may be explained by differences in measurement protocols or sample handling, such as applying 
voltage ramps compared to discrete voltage steps, associated differences in the holding potential or RBC storage 
before performing the recordings16.
In this study we also show that differences in current properties are not only characteristic of the circulating 
RBCs, but can also be tracked down to erythroblasts differentiated ex vivo from peripheral patient CD34+ cells. 
The effects in precursor cells are more pronounced compared to mature circulating RBCs (Fig. 4 vs. Fig. 3), 
which is not surprising regarding the low abundance of the Gardos channel in mature circulating RBCs. Based 
on patch-clamp recordings Grygorczyk et al.14 estimated that approximately 75% of RBCs have between 1 and 5 
channels per cell whereas the rest have approximately 11 to 55 channels per cell; Wolff et al.17 estimated an even 
lower number of an uniform mean of 1 to 3 channels per cell.
Figure 4. Current-voltage plots for the erythroid precursor cells of the healthy controls (n = 17, black circles) 
and II-4 patient (open or grey symbols). (A) Cells were exposed to a ramp protocol three times in a row. Each 
next hyperpolarization-depolarization cycle was followed by an increase in current at positive potentials in 
the EPCs of II.4 patient (n = 24, 19 and 12 for the ramps 1, 2 and 3), whereas for the cells derived from healthy 
donors it was never the case. (B) Increase in electric current at positive potential in cells of patient II.4 caused 
by repetitive ramp protocol application could be blocked by pre-treatment of cells with 15 µM methyl isobutyl 
amiloride (MIA, grey squares, n = 14), 15 µM TRAM-34 (black squares, n = 7) or omission of the extracellular 
Ca2+ (open triangles, n = 14). All I/V curves presented in the panel represent the values obtained for the third 
ramp protocol. Data are shown as mean ± SD.
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To get a mechanistic link between the Gardos channel R352H mutation, the cellular properties and eventually 
the clinical phenotype, we also measured the activity of single ion transporters using 86Rb+ as a tracer for K+ flux 
experiments, we evaluated the intracellular ions contents and the effects on RBC glycolysis. The observation of a 
3–4 fold increase of unidirectional K+(86Rb+) fluxes in patient II.4 suggests that mutant R352H activate a series of 
compensatory processes resulting in the prevention of terminal dehydration.
A possible scenario is presented in the scheme reported in Fig. 7. Following the increased activity of the 
mutated Gardos channel and the subsequent excessive loss of cell K+, K+ influx through NKCC and possibly 
KCC, is enhanced. Moreover, the NKCC-mediated Na+ accumulation is further enhanced by activation of the 
Na+/H+ exchanger (NHE) as confirmed by our patch-clamp data on erythroid cells using NHE specific inhib-
itors and in line with the increase of the intracellular Na+ content observed in the splenectomized II.4 patient. 
The abnormally high intracellular Na+ content results in cell swelling, triggers activation of the Na,K-ATPase 
and increases energy consumption18, 19 as demonstrated by the ATP reduction and stimulation of glycolysis. 
Interestingly we found Ca2+ overload and increased heterogeneity of the inter- and intra-cellular distribution of 
Ca2+ in RBCs of both patients as assessed by flow cytometry and confocal fluorescence live-cell imaging. Such an 
overload could possibly be aided by activation of the mechanosensitive, thus swelling activated, PIEZO1 channels 
or through other Ca2+ entry pathways e.g. voltage-sensitive cation channels; these latter are possibly implied as 
observed by the increase of EPCs current as a result of repeated voltage ramps, then abolished by external Ca2+ 
removal.
Increase of the Ca2+ content in patients RBCs may trigger numerous Ca2+-dependent processes20 such as 
scramblase activation, calpain cleavage, flippase inhibition and ultimately provides a positive feedback loop for 
the Gardos channel itself. The markedly up-regulated intracellular Ca2+ levels in RBCs may contribute to prema-
ture removal of these RBCs from the circulation21. Thus based on our data, a point mutation in a single channel 
present in a low number of copies (3–200/cell according to different authors)14, 17, 22 in RBCs may interfere with 
the regulation of multiple ion transport systems and, consequently, with metabolic rates, membrane stability and 
cellular morphology of circulating RBCs as well as erythroblasts.
Recently, in a very short period of time, three different groups described mutations in the KCNN4 gene associ-
ated with DHSt10, 11, 12; our report brings to 7 the number of affected families. The identification of R352H as a de 
novo event in patient II.4 reinforces the hypothesis that it could be a mutational hotspot11.
Figure 5. Activity of ion transporters, intracellular Na+ and ATP content in circulating RBCs. (A) 
Unidirecitonal K+(86Rb+) influx into RBCs of a healthy control and patient II.4. Shown in the panel are bulk K+ 
influx and the influx components carried by the Na,K-pump (ouabain-sensitive flux) and the fluxes mediated 
by the chloride-dependent influx mediated by Na,K,2Cl-, K,Cl-cotransporters, and Gardos channel activity 
(TRAM-34-sensitive flux). White bars show the flux values for RBCs of healthy control and black bars are for 
the fluxes in II.4 patient’s RBCs. Numbers above the bars indicate the contribution of each ion transporter into 
the total influx of either patient or healthy control in %. Intracellular Na+ (B) and ATP (C) content of RBCs 
of the healthy I.2 (white bar) and patient II.4 (black bar) measured in triplicates on one occasion. Data are 
mean ± SD. Although statistical analysis could not be performed for single experiments all the values show clear 
difference between the I.2 and II.4 (for intracellular Na+ and ATP levels) as well between the RBCs of II.4 and 
identically treated healthy control for all the K+(86Rb+) flux components.
www.nature.com/scientificreports/
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Figure 6. Calcium handling in patients with mutated Gardos channel. (A) Representative confocal images 
of RBCs from controls and the patients loaded with the Ca2+-sensitive dye Fluo-4. A brighter fluorescence 
corresponds to a higher Ca2+-concentration. White arrows indicate sequestration of Ca2+ in intracellular 
vescicles. (B) Statistical analysis of wide field fluorescence Fluo-4 recordings for healthy donors (white bar, 
n = 2495 cells), patient II.4 (black shaded bar, n = 1257 cells) and patient III.1 (grey bar, n = 1402 cells). Because 
values are not Gaussian distributed we plotted boxes with whiskers from the 10th to 90th percentile. Significance 
was checked using the Mann-Whitney test; *, ***denote p < 0.05, and 0.001 respectively. (C–F) Intracellular 
Ca2+ (assessed as Ca2+-dependent fluorescence of Fluo-4) in RBCs of healthy controls and patients II.4 and 
III.1 measured by flow cytometry. Intracellular Ca2+ was measured at baseline and then the measurements 
were repeated immediately after the initiation of osmotic swelling by adding a bolus of distilled water to 
dilute the RBC suspension in isosmotic buffer by 1/3 (Swelling). (C) Readout for all RBCs in suspension; (D) 
Amount of cells forming “high Ca2+ fraction” (A-gated fraction, flow cytometric analysis shown in panel 
(E); (F) fluorescence intensity of Fluo-4 in this “high Ca2+ fraction”. All the experiments were performed in 
two occasions, and each time triple measurements were performed for each conditions. *, ** and ***denote 
p < 0.05, 0.01 and 0.001 respectively compared to healthy control. #, ## and ### stand for p < 0.05, 0.01 and 0.001 
for osmotically compromised cells compared to the baseline values in either control or patients.
www.nature.com/scientificreports/
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The patients with KCNN4 mutations reported so far display a wide phenotypic heterogeneity, ranging from 
severe fetal anemia requiring in utero transfusions to mild or compensated hemolysis (Supplementary Table I). It 
is worth mentioning that all the 8 splenectomised patients do not display the increased susceptibility to throm-
botic events commonly reported in DHSt23, 24; this holds especially true when considering the very long follow-up 
after splenectomy of patient II.4. An explanation for such an observation may reside in the increasingly recog-
nized interplay between mechano-sensitive channels like PIEZO1 and the Gardos channel3, 25. When passing 
capillaries or other constrictions of smaller diameter, the RBCs mechano-sensitive channels that conduct Ca2+ 
are activated and the consecutive Ca2+-flashes activate Gardos channels for a fast and transient volume adapta-
tion. This concept is supported by our measurements of filterability, since both inhibition of mechano-sensitive 
channels (with GsMTx-4) and inhibition of the Gardos channel (with TRAM-34) decrease filterability. Thus if the 
function of mechano-sensitive channels is impaired, such as Piezo1 in typical DHSt26, the above described volume 
adaptation does not work properly, RBCs can get stuck and form aggregates caused by intercellular adhesion27. 
In the presence of the spleen, RBCs lacking the adaptive volume regulation get stacked in the splenic slits and 
are consecutively removed, whereas in splenectomized patients they circulate leading to thrombotic events. In 
patients with the KCNN4 mutation, Gardos channels are more sensitive to Ca2+ and more active, and with such 
compensation at hand, volume adaptation is less impaired suggesting a reduced post-splenectomy thrombotic 
risk, to be confirmed in further studies.
The dyserythropoietic features detected in the bone marrow of II.4 supports the hypothesis that KCNN4 may 
play a role in erythroid maturation, suggested also by the I-V-curves in precursor cells indicating a higher abun-
dance of Gardos channels in erythroid precursors compared to mature RBCs; therefore, iron overload detected 
in our and other patients with KCNN4 mutation11 may be a consequence of dyserythropoiesis, similar to what 
is reported in DHSt with PIEZO1 mutations28, 29. The history of the patients reported here confirms that con-
genital hemolytic anemia due to abnormal cation permeability may represent a diagnostic challenge that is now 
overcome by means of the new Next Generation Sequencing technology approaches. Patient II.4 received a diag-
nosis of hereditary spherocytosis in infancy and was splenectomized without clinical improvement; the finding 
with SDS-PAGE of a spectrin deficiency may be considered a secondary effect of a membrane perturbation30, 31 
disclosed by splenectomy32, since it is absent in the daughter, and no mutations in the spectrin or other related 
genes were detected by whole exome sequencing. The phenotypic variability, the possible high frequency of de 
novo variants, and the absence of specific biological tests make the diagnosis of this variant of hereditary stomat-
ocytosis particularly difficult. The widespread use of NGS technology is likely to result in a greater than expected 
frequency of Gardos channelopathies.
In conclusion, this study shows that KCNN4 R352H mutation determines, together with an increased Gardos 
channel activity, an unexpected activation of multiple compensatory changes, in absence of any other abnormal-
ities of red cell membrane or channel proteins.
Figure 7. Schematic representation of the proposed mechanism observed in RBCs from patient carrying 
R352H KCNN4 mutation. Top: Normal RBC; Middle: Expected effect of a more active Gardos Channel, Bottom: 
observed effects in KCNN4 R352H mutant RBCs.
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We suggest that the ‘Gardos channelopathy’ is a more complex pathology, to some extent different from the 
common DHSt type, and that distinct mutations in the Gardos channel may have a diverse impact on cell volume 
regulation mechanisms. In fact, as shown in Supplementary Table I, patients with R352H mutation are character-
ized by milder dehydratation and normal Osmoscan curve when compared to V282M/E cases that display typical 
features of hereditary xerocytosis33, 34, (median MCHC R352H 35 g/dL vs. MCHC V282M/E 36.4).
This observation is also in line with the recent study by Rapetti-Mauss et al. aimed to define the sensitivity 
of KCNN4 mutants to Senicapoc, where it was demonstrated that the three mutations (R352H, V282M/E) do 
not share a common mechanism in altering channel characteristics and display significantly different Senicapoc 
sensitivity13, 35. Further investigation of the molecular mechanisms behind the cross-talk between numerous ion 
transporters and exploration of the causes of the abnormal hyper-sensitivity to mechanic stimulation and of 
Ca2+ overload may give more clues to the optimization of diagnosis and therapeutic approaches for this group of 
patients.
Methods
All the diagnostic procedures and investigations were performed in accordance with the Helsinki Declaration 
of 1975. Patients had given their consent for the participation to this study. The study was approved by Ethical 
Committee at Fondazione IRCCS Ca’ Granda Ospedale Maggiore of Milan.
Hematologic investigations. Routine hematological investigations were carried out according to Dacie 
& Lewis36. RBC osmotic fragility was evaluated by NaCl test on fresh and incubated blood at 37 °C overnight, 
acidified glycerol lysis test (AGLT), and Pink test as described elsewhere37. EMA-binding was performed by the 
method of King et al.38, RBC enzymes’ activities were determined according to Beutler39, and membrane proteins 
were analyzed by SDS-PAGE40, 41.
Osmoscan was performed by Laser-assisted Optical Rotation Cell Analyzer (LoRRca MaxSis, Mechatronics, 
Hoorn, The Netherlands) following the manufacturer’s instructions; samples were tested in different experimental 
conditions (fresh blood, after 24 h at 4 °C) and drawn in Heparin and EDTA to ascertain whether incubation and 
anticoagulants may affect the curve as hypothesized by Badens & Guizouarn42. The Osmoscan curve performed 
after 24 h incubation at 37 °C was markedly altered in both patients and controls.
All the analyses were performed with cells of patient II.4, and of patient III.1 when feasible due to the limita-
tion of blood sample size (child).
Next Generation Sequencing. Library preparation, Whole Exome Sequencing and data analysis, per-
formed before the report in literature of new mutations in KCNN4, were provided as service by Genomnia srl 
(Lainate, Italy), using the Life Technolgies SOLiD 5500xl Genetic Analysis Sequencer. For details please refer to 
Supplementary Information.
The mutation was confirmed by Sanger sequencing (ABI PRISM 310 Genetic Analyzer, Applied Biosystems).
Isolation and culturing of erythroid precursor cells (EPCs). Heparinised peripheral blood (PB) sam-
ples of patient II.4 and a healthy control were obtained and processed within 5 h after collection. Mononuclear 
cells were isolated on a Ficoll-Paque PLUS gradient (GE-Healthcare, Dietikon, Switzerland), and cultured in a 
two-phase liquid system as described elsewhere43. Late-stage erythroblasts were then used for assessment of elec-
tric currents across the EPCs membranes by means of patch-clamp.
Filterability. The filterability test was performed with RBCs of patients II.4 and III.1 and controls by a mod-
ified method originally developed by Beutler et al.44 for the depletion of leukocytes. To assess the impact of 
mechano-sensitve channels and Gardos channel into filterability, healthy RBCs were treated with the blocker of 
mechano-sensitive channels (GsMTx-4) and the Gardos channel blocker TRAM-34 prior to the filtration onset. 
For a detailed description please refer to Supplementary Information.
Separation of RBCs on Percoll density gradient. Separation of RBCs into the low (L), medium (M) and 
high (D) density fractions was performed as described elsewhere [21]. Whole blood (1–1.5 mL) was overlayed on 
12.5 mL 90% isotonic Percoll solution (GE Healthcare; density 1.130 g/mL) prepared by mixing 90 mL of Percoll 
with 10 mL × 10 PBS (Sigma-Aldrich) and 11 mL × 1 PBS (Sigma-Aldrich). The resulting samples were centri-
fuged using Sorvall RC-5C plus centrifuge equipped with a SM-24 rotor at 4 °C for 30 min at 45,000× g.
Patch-clamp measurements. Patch-clamp measurements on circulating RBCs were performed with a 
NPC-16 Patchliner (Nanion Technologies, Munich, Germany) and on the EPCs of patient II.4 with a conven-
tional patch-clamp setup (Axon CNS, Molecular Devices, Downingtown, PA, USA) The resistance of the chips 
with internal and external solutions as follows (in mM): KCl 70, KF 70, HEPES 30, CaCl2 0.5, pH = 7.2 adjusted 
with KOH (internal) and KCl 140, MgCl2 5, CaCl2 6, D-glucose 2.5, HEPES 10, pH = 7.3 adjusted with KOH 
(external) was between 5 and 8 MΩ. Gigaseals were considered successful if exceeding 5 GΩ (with most cells 
they were 10 GΩ and above). Gigaseal formation was facilitated by the use of a seal enhancing solution as recom-
mended by the Patchliner manufacturer and containing (in mM): NaCl 80, KCl 3, MgCl2 10, CaCl2 35, HEPES 
10, pH = 7.3 adjusted with NaOH. The seal enhancing solution was only used to help obtaining the very high 
gigaohmic contact between the cell and the chip and in the whole-cell configuration was replaced by the exter-
nal solution. Whole-cell configuration was achieved by negative pressure suction pulses between −45 mbar and 
−150 mbar and its formation judged by the appearance of sharp capacitive transients. Whole-cell patch-clamp 
recordings were conducted at room temperature using voltage steps from −130 mV to 70 mV for 500 ms in 20 mV 
increments at 5 s intervals, the holding potential being set at −30 mV. Gardos current differences between patient 
II.4 and healthy donors were assessed by comparing the block of currents by 1 µM TRAM-34. To reduce inter-cell 
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variability data are expressed as normalized current which is the ratio of the current under specified experimental 
conditions i.e. before (control) and in the presence of 1 µM TRAM-34 at selected membrane potentials, to the 
current at +70 mV determined 30–60 s before starting the control (control) measurement. Data are presented as 
means ± SEMs (n represents the number of cells).
Such an approach to avoid inter-cell variability we have successfully used45. A two-tailed, paired t-test was 
applied on the normalized currents to assess the difference in the current with and without 1 µM TRAM at every 
potential.
Assessment of the fluctuations of the current (obvious in Fig. 3A Ctrl-basal and II.4-basal and abolished by 
TRAM as seen in Ctrl-TRAM and II.4-TRAM) allowed us to account also for the cells with only a few channels. 
Analysis of the kinetics of the traces giving us a sensitive quantitative measure of the Gardos channel activity 
in all cells was done in the following way: we considered the variance of the current trace at −110 mV for each 
cell. From the variance we calculated the standard deviation for the trace (this was done separately for the trace 
without TRAM and for the trace with 1 μM TRAM). We then subtracted the two standard deviations (these are 
paired data of the same cell). This difference was considered as a read-out of the Gardos channel activity (more 
fluctuations = higher activity). 23 cells from the patient and 27 cells from the control were compared using a 
non-paired t-test (Fig. 3Cb).
Electric currents through the membranes of EPCs of a patient (II.4) were assessed as described elsewhere46. 
Whole-cell voltage clamp experiments were performed during ex-vivo hematopoiesis between day 11 and day 
13. EPCs were plated on poly-L-lysine (0.01% vol/wt in H2O) coated cover glass slides and voltage-clamped at 
room temperature under constant perfusion with extracellular solution. For data acquisition and analysis the 
Axopatch 200B amplifier, Digidata 1440A, and pClamp 10.3 were used (all by Axon CNS, Molecular Devices, 
Downingtown, PA, USA).
The leak current was subtracted manually and the data were filtered at 5 kHz. A voltage-step protocol was 
used to asses the passive electrophysiological properties. The voltage was hold at −70 mV and stepped for 200 ms 
from −120 mV to +80 mV, in 10 mV increment. The protocol was repeated 1–3 times. The standard intracellular 
solution consisted of (in mM) 117 KCl, 11 HEPES, 1 EGTA, 10 NaCl, 2 MgCl2, 2 Na2ATP, adjusted to pH 7.2 
with KOH was used. The standard extracellular solution consisted of (in mM) 135 NaCl, 5 KCl, 5 HEPES, 10 
D-glucose, 1.5 CaCl2, adjusted to pH 7.35 with NaOH. When stated, extracellular solution was Ca2+-free and 
containing 1 mM EGTA or supplemented with the inhibitor of the Na+/H+ exchanger methyl isobuthyl amiloride 
(MIA) and blocker of Gardos channel TRAM-34 (final concentration for both blockers was 15 µM). To ensure 
fast drug application, a Rapid Solution Changer System was used, which allowed solution changes within 20 ms. 
Data are presented as means ± SEM.
K+ (86Rb+) influx. Unidirectional influx rates for K+ were assessed by using 86Rb+ as a tracer as previously 
described47. Total unidirectional K+ influx was detected in erythrocytes incubated at hematocrit of 5–8% in the 
standard incubation medium containing (in mM): 145 NaCl, 4 KCl, 0.15 MgSO4, 2 CaCl2, 10 glucose, 10 sucrose, 
and 10 HEPES-Tris, 0.3 L-arginine, 0.3 L-glutamate, and 0.3 L-glycine, pH 7.4 at 37 °C. Chloride-free medium 
contained (in mM): 145 NaNO3 and 4 KNO3 instead of NaCl and KCl respectively. Ouabain (final concentration 
100 µM), and TRAM-34 (10 µM) were used as selective blockers of the Na,K-ATPase, and the Gardos channel, 
respectively. Cells were pre-incubated for 15 min to enable binding of the inhibitors to their targets. Influx was 
then initiated and measured by addition of 86RbCl (104 Bq/mL) and aliquots of the RBC suspension collected 10, 
20, 30, 45, and 60 min after the onset of incubation. The cells were washed free from extracellular tracer, lysed 
and the amount of 86Rb+ accumulated in erythrocytes was measured and normalized to the amount of the radi-
oactive tracer in the incubation medium. Ouabain-sensitive K+ influx was denoted as active K+ uptake by the 
Na,K-ATPase. Chloride-dependent K+ influx in the presence of ouabain represented cumulative activity of the 
Na-K-2Cl- and K-Cl-cotransporters. Treatment with TRAM-34 in the presence of ouabain resulted in the inhibi-
tion of K+ influx through the Gardos channels.
Ca2+-imaging. The Ca2+ imaging was performed based on the Ca2+-fluorophor Fluo-4 (Life technologies, 
Carlsbad, CA, USA) using a set-up as previously described48. Basal Ca2+-related fluorescence was measured as 
described before49. To evaluate the cellular distribution, confocal images of Fluo-4 loaded RBCs were recorded on 
a TCS SP5 (Leica, Mannheim, Germany)50.
Detection of the intracellular Ca2+ levels in RBCs by flow cytometry. Intracellular Ca2+ levels in 
RBC fractions of healthy control subjects as well as of II-4 and III-1 patients were detected by flow cytometry. 2 µL 
of whole blood suspended in the incubation medium was loaded Fluo-4 AM (Life technologies, Carlsbad, CA, 
USA). Thereafter, Ca2+-dependent fluorescence intensity was measured in RBCs using Gallios flow cytometer 
(Beckman Coulter). Triple measurements (100.000 cells/measurement) were performed and averaged for each 
condition.
Due to the RBCs marked heterogeneity in sensitivity to mechanical stimulation, and because Ca2+ uptake is 
acute and transient, swelling was chosen as the most appropriate approach to study RBCs sensitivity to mechan-
ical stimulation.
Sensitivity of Ca2+ uptake to swelling was tested as follows. Basal intracellular Ca2+ levels in RBCs of patients 
and controls were measured and then the samples were diluted with distilled water (0.25 mL H2O added to 0.5 mL 
sample) and Ca2+ measurements repeated directly thereafter.
Statistics. Unless otherwise stated statistical analysis was performed using one-way ANOVA with 
Bonferroni’s multiple comparison test or Student’s paired t-test, as appropriate (with normal distribution of the 
www.nature.com/scientificreports/
1 2Scientific RepoRts | 7: 1744  | DOI:10.1038/s41598-017-01591-w
values), Kruskal-Wallis with Dunn’s post test (when the distribution was not normal). For all tests, significance 
level was set at P < 0.05.
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